Showing results (11-20 of 340) with videos related to

Sort By:
Pageof 34
Investigative Ophthalmology & Visual Science|April 7, 2026
Ocular Glymphatic System: Its Modulation and Role in Intraocular TumorsJasmine H Francis, David H Abramson
Ocular Oncology and Pathology|May 29, 2026
Reese, Ellsworth, and the Classification of RetinoblastomaElla R Feiner, David H Abramson
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|June 25, 2015
Update on Ophthalmic Oncology 2012: Advances in Retinoblastoma and Uveal MelanomaAmy C Schefler, David H Abramson
Current Opinion in Ophthalmology|October 16, 2008
Retinoblastoma: what is new in 2007-2008Amy C Schefler, David H Abramson
American Journal of Ophthalmology Case Reports|October 6, 2025
High-dose topotecan (90 and 180 μG) for recurrent subretinal and vitreous seeding in retinoblastomaDavid H Abramson, Jasmine H Francis
Translational Vision Science & Technology|October 6, 2025
Blood-Based Cell-Free DNA in Ophthalmic OncologyJasmine H Francis, David H Abramson
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|June 25, 2015
Update on Ophthalmic Oncology 2013: Retinoblastoma and Uveal MelanomaJasmine H Francis, David H Abramson
Journal of Pediatric Ophthalmology and Strabismus|March 28, 2023
Intravitreal Topotecan 90 µg for Recurrent Solid Retinoblastoma Tumors Is Effective and Not ToxicDavid H Abramson, Jasmine H Francis
American Journal of Ophthalmology|October 18, 2005
Periocular mucosa-associated lymphoid/low grade lymphomas: treatment with antibioticsDavid H Abramson, Indira Rollins, Morton Coleman
Pageof 34